MMP9 and prostate cancer: Zoledronate as well as alendronate has been found to inhibit secretion and activity of MMP-2 and MMP-9 by tumor cells and tumor-infiltrating macrophages in mouse models of cervical cancer [19] and prostate cancer [50].